畜牧兽医学报 ›› 2006, Vol. 37 ›› Issue (4): 361-367.doi:

• 预防兽医 • 上一篇    下一篇

以小鼠为模型评价重组伪狂犬病病毒rPRV-HA的免疫效力

郑宝亮;周国辉; 田志军; 仇华吉; 杨焕良; 尹训南; 胡守萍; 童光志   

  1. 1.中国农业科学院哈尔滨兽医研究所 兽医生物技术国家重点实验室,哈尔滨150001;2.东北农业大学动物医学院,哈尔滨150030
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2006-04-25 发布日期:2006-04-25

Efficacy Evaluation of a Recombinant Pseudorabies Virus Expressing the Hemagglutinin Gene from H3N2 Subtype Swine Influenza Virus as Vaccine in a Mouse Model

ZHENG Bao-liang;ZHOU Guo-hui;TIAN Zhi-jun;QIU Hua-ji;YANG Huan-liang;YIN Xun-nan;HU Shou-ping; TONG Guang-zhi
  

  1. 1. National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150001, China; 2. College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China
  • Received:1900-01-01 Revised:1900-01-01 Online:2006-04-25 Published:2006-04-25

摘要: 以小鼠为动物模型,对此前构建的表达H3N2亚型猪流感病毒(SIV)血凝素(HA)基因的重组伪狂犬病病毒(rPRV-HA)进行了免疫效力评价。按每只105.0 TCID50 rPRV-HA的剂量通过滴鼻接种8周龄雌性BALB/c小鼠(n=60),同时设BarthaK61免疫对照组(n=60)、非免疫攻毒对照组(n=20)和非免疫不攻毒对照组(n=10)。于免疫后不同时间分别从rPRV-HA免疫组和Bartha-K61免疫对照组随机剖杀一定数量的小鼠,其余小鼠于免疫后第28天用105.0 TCID50同亚型SIV 毒株A/Swine/Heilongjiang/74/2000(H3N2)进行强毒攻击。攻毒后第4、7、14天分别剖杀小鼠,进行间接免疫荧光、病毒分离、血清学和病理组织学检测。结果表明,重组病毒主要分布于肺脏;免疫后14 d起,从rPRV-HA免疫组及Bartha-K61免疫对照组均可检测到针对PRV的荧光抗体;从rPRV-HA免疫组可以检测到针对SIV的荧光抗体和血凝抑制抗体,而各对照组均呈阴性。攻毒后从rPRV-HA免疫组小鼠未分离到攻击病毒,血凝抑制抗体显著升高,病理变化显著轻于对照组,表明rPRV-HA免疫小鼠可以抵抗同亚型SIV的攻击,可以作为rPRV-HA免疫效力评价模型。

Abstract: A recombinant pseudorabies virus (PRV) (rPRV-HA) expressing the hemagglutinin (HA) gene from H3N2 subtype swine influenza virus (SIV) was evaluated in a mouse model. A total of 150 8-week-old female BALB/c mice were used in this study. The mice were each inoculated intranasally with 105.0 TCID50 of rPRV-HA (rPRV-HA group, n=60) or attenuated vaccine Bartha-K61 (Bartha-K61 group, n=60), and another two unimmunized groups served as challenged group (n=20) or unchallenged group (n=10). Some mice in rPRV-HA and Bartha-K61 groups were sacrificed for antigen detection and virus isolation at different days post-immunization (DPI), and the others were each challenged with 105.0 TCID50 of the same subtype SIV 28 DPI. Recombinant virus could be detected in the lung of rPRV-HA-immunized mice. Antibody responses to PRV were detected by indirect immunofluorescence assay, but not by seroneutralization test, in both rPRV-HA and Bartha-K61 groups. SIV-specific antibodies were detected by hemagglutination inhibition test only in rPRV-HA group 14 DPI. The rPRV-HA-immunized mice were protected from homologous SIV challenge, as indicated by limiting virus replication and pathological changes of the organs, and boosted antibody responses to SIV post-challenge.